Exposure to mold and the mycotoxins it produces can drive chronic inflammation, immune dysregulation, and neurological symptoms that persist long after leaving the environment.
Mold illness presents as fatigue, brain fog, headaches, sinus and respiratory symptoms, sensitivity to smells and chemicals, and mood change — a pattern that maps onto many other diagnoses.
Patients are often treated for allergies, anxiety, or chronic fatigue for years before exposure is ever considered.
Dr. Kellman assesses mycotoxin burden alongside immune and inflammatory status, because the illness is driven by the immune response to exposure as much as by the exposure itself.
Treatment addresses the ongoing source, supports binding and elimination of mycotoxins, calms the inflammatory response, and restores microbiome and mitochondrial function.
Because mold illness is driven substantially by the immune and inflammatory response to exposure, which can persist after the exposure ends. Stored mycotoxin burden also continues to affect the body until it is cleared.
Yes. Brain fog, headaches, poor concentration, and mood change are commonly reported and reflect the neuroinflammatory effect of mycotoxin exposure.